You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibodies

Full name:
anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antibodies (RELB)
On www.antibodies-online.com are 152 V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibodies from 22 different suppliers available. Additionally we are shipping V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Kits (21) and V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Proteins (10) and many more products for this protein. A total of 199 V-Rel Reticuloendotheliosis Viral Oncogene Homolog B products are currently listed.
Synonyms:
GC-rich, I-REL, IREL, REL-B, relb-A, shep, XRelB
list all antibodies Gene Name GeneID UniProt
RELB 19698 Q04863
RELB 5971 Q01201
RELB 100360982  

Show all species

Show all synonyms

Most Popular Reactivities for anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibodies

Select your species and application

anti-Mouse (Murine) Antibodies:

anti-Human Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antibodies

Go to our pre-filtered search.

Top referenced anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Antibodies

  1. Human Polyclonal RELB Primary Antibody for IHC (p), WB - ABIN197016 : Marienfeld, Berberich-Siebelt, Berberich, Denk, Serfling, Neumann: Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control. in Oncogene 2002 (PubMed)
    Show all 3 references for ABIN197016

  2. Human Polyclonal RELB Primary Antibody for WB - ABIN197500 : Pyz, Naidenko, Miyake, Yamamura, Berberich, Cardell, Kronenberg, Herrmann: The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR. in Journal of immunology (Baltimore, Md. : 1950) 2006 (PubMed)
    Show all 2 references for ABIN197500

  3. Human Polyclonal RELB Primary Antibody for WB - ABIN2780295 : Phan, Cho, Sainz-Lyon, Shin, Greenhalgh: CD14-dependent modulation of NF-kappaB alternative splicing in the lung after burn injury. in Gene 2006 (PubMed)

More Antibodies against V-Rel Reticuloendotheliosis Viral Oncogene Homolog B Interaction Partners

Mouse (Murine) V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) interaction partners

  1. AhR and NF-kappaB/Rel protein binding profile within the 3'IghRR mediates the inhibitory effects of TCDD on Ig expression and therefore antibody levels.

  2. Relb is necessary for the effective production of downstream RANK(+) medullary thymic epithelial cell progenitors.

  3. we identify in this study a critical role for the combined activity of the RELB and NF-kappaB2 subunits in B cell homeostasis that cannot be compensated for by the canonical NF-kappaB (show NFKB1 Antibodies) pathway under physiological conditions.

  4. results indicate that BAFF (show TNFSF13B Antibodies) signals coordinate both RelB and cRel activities to ensure survival during peripheral B-cell maturation (show TNFRSF17 Antibodies)

  5. phosphorylation of DBC1 (show DBC1 Antibodies) at its C terminus by IKKalpha (show CHUK Antibodies) facilitates its interaction with RelB and IKKalpha (show CHUK Antibodies), indicating that DBC1 (show DBC1 Antibodies)-mediated suppression of alternative NF-kappaB (show NFKB1 Antibodies) is regulated by IKKalpha (show CHUK Antibodies).

  6. Data show that IL-1 (show IL1A Antibodies)-induced transcriptin factor RelB/NF-kappa B p50 (show NFKB1 Antibodies) Subunit complex formation was further promoted by oncostatin M (show OSM Antibodies) and that these complexes directly bound to the secreted protein cartilage glycoprotein 39 (YKL-40 (show CHI3L1 Antibodies)) promoter.

  7. RelB serine 472 phosphorylation status controls MMP3 (show MMP3 Antibodies) expression and promigration activity downstream of TNF (show TNF Antibodies) receptors.

  8. Sequential actions of SIRT1 (show SIRT1 Antibodies)-RELB-SIRT3 (show SIRT3 Antibodies) coordinate nuclear-mitochondrial communication during immunometabolic adaptation to acute inflammation and sepsis.

  9. findings indicate that RelB negatively regulates bone mass as mice age and limits bone formation in healing bone defects, suggesting that inhibition of RelB could reduce age-related bone loss and enhance bone repair

  10. RelB/microRNA-146a axis attenuates exaggerated COX-2 (show COX2 Antibodies) expression in response to cigarette smoke in lung fibroblasts.

Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) interaction partners

  1. Knockdown of ADGRG2 breast cancer cell lines resulted in a strong reduction in cell adhesion and subsequent cell migration which was associated with a selective reduction in RelB.

  2. the role of RelB on lymphocyte development in humans was shown.

  3. In conclusion, DECs show a unique hypo-responsive phenotype to the pro-inflammatory stimulus LPS (show IRF6 Antibodies) in order to control the inflammatory response at feto-maternal interface.

  4. Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time.

  5. results suggest that glucocorticoids induce a transcription complex consisting of RelB/p52 (show FKBP4 Antibodies), CBP (show CREBBP Antibodies), and HDAC1 (show HDAC1 Antibodies) that triggers a dynamic acetylation-mediated epigenetic change to induce CRH (show CRH Antibodies) expression in full-term human placenta.

  6. HDAC4 (show HDAC4 Antibodies)-RelB-p52 (show FKBP4 Antibodies) complex maintains repressive chromatin around proapoptotic genes Bim (show BCL2L11 Antibodies) and BMF (show BMF Antibodies) and regulates multiple myeloma survival and growth

  7. RELB enhances proliferation of human-induced pluripotent stem cells without affecting their pluripotency. RELB interacts with LIN28A (show LIN28A Antibodies) and IMP3 (show IGF2BP3 Antibodies).

  8. Although RelB nuclear frequency alone did not predict recurrence, the presence of activated RelB reduced the risk of recurrence associated with the activation of p65 (show GORASP1 Antibodies).

  9. In non-small cell lung cancer, RelB expression was identified in proliferating tumor cells. tumor RelB expression was an independent predictor of lymph node metastasis

  10. Basal expression of RelB was significantly lower in lung cells derived from smokers with and without COPD (show ARCN1 Antibodies).

Cow (Bovine) V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) interaction partners

  1. Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription.

Xenopus laevis V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) interaction partners

  1. XRelB can partially substitute for several, but not all, functions of the Dorsal protein in Drosophila embryos.

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antigen Profile

Antigen Summary

NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF- kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF- kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. Stimulates promoter activity in the presence of p49- and p50-NF-kappa-B. Neither associates with DNA nor with p65-NF-kappa-B (By similarity).

Alternative names and synonyms associated with V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB)

  • avian reticuloendotheliosis viral (v-rel) oncogene related B (Relb) antibody
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (RELB) antibody
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (Relb) antibody
  • v-rel avian reticuloendotheliosis viral oncogene homolog B (relb) antibody
  • v-rel reticuloendotheliosis viral oncogene homolog B (RELB) antibody
  • GC-rich antibody
  • I-REL antibody
  • IREL antibody
  • REL-B antibody
  • relb-A antibody
  • shep antibody
  • XRelB antibody

Protein level used designations for RELB

transcription factor RelB , v-rel avian reticuloendotheliosis viral oncogene homolog B (nuclear factor of kappa light polypeptide gene enhancer in B-cells 3) , v-rel reticuloendotheliosis viral oncogene homolog B, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 , avian reticuloendotheliosis viral (v-rel) oncogene related B , v-rel reticuloendotheliosis viral oncogene homolog B , transcription factor RelB homolog

GENE ID SPECIES
19698 Mus musculus
5971 Homo sapiens
100360982 Rattus norvegicus
522670 Bos taurus
378663 Xenopus laevis
484454 Canis lupus familiaris
100622609 Sus scrofa
395656 Gallus gallus
Selected quality suppliers for anti-V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) Antibodies
Did you look for something else?